|
|
|
|
|
|
|
¸ñÂ÷ |
|
Section I: Introduction 1. Epigenetics of Human Disease: An Overview Section II: Methodology 2. Methods and Strategies to Determine Epigenetic Variation in Human Disease 3. DNA Methylation-Based Measures of Biological Aging 4. Bioinformatics of Epigenomic Data Generated From Next-Generation Sequencing Section III: Human Cancer 5. DNA Methylation Alterations in Human Cancer 6. Alterations of Histone Modifications in Cancer 7. MicroRNA in Cancer 8. Epigenetic Approaches to Cancer Therapy Section IV: Neurological Disease 9. Epigenetics in Neurobehavioral Disease 10. Emerging Role of Epigenetics in Human Neurodevelopmental Disorders 11. The Epigenetics of Alzheimer's and Other Neurodegenerative Disorders 12. Epigenetic Modulation of Human Neurobiological Disorders Section V: Autoimmune Disease 13. Epigenetic Basis of Autoimmune Disorders in Humans 14. Approaches to Autoimmune Diseases Using Epigenetic Therapy Section VI: Metabolic Disorders 15. Epigenomics and Human Obesity 16. Epigenetic Approaches to Control Obesity 17. Early-Life Nutrition, Epigenetics and Prevention of Obesity 18. Epigenetics of Diabetes in Humans 19. The Potential of Epigenetic Compounds in Treating Diabetes Section VII: Other Disorders/Diseases 20. Epigenetic-Processes Driven Disorders and Therapeutics 21. Epigenetics of Allergic Diseases Allergies, Eczema, Asthma, and Rhinitis 22. Therapy of Airway Disease:? Epigenetic Potential 23. The Role of Epigenetics in Cardiovascular Disease 24. Epigenetic Treatment Approaches to Cardiovascular Disease 25. Epigenetics and Human Infectious Diseases 26. Therapy of Infectious Diseases Using Epigenetic Approaches 27. Translational Aspects of the Endometriosis Epigenome 28. Aberrant DNA Methylation Patterns in Gynecologic Cancers: Implications for Prevention and Therapy 29. Epigenetics in Human Reproduction and Gynecologic Diseases Section VIII: Development, Aging and Transgenerational Effects 30. Epigenetics of Transgenerational Inheritance of Disease 31. Epigenomic Mechanisms of Human Developmental Disorders 32. Therapeutic Approaches to Imprinting Diseases 33. Stem Cell Epigenetics and Human Disease 34. Noncoding RNA Regulatory Networks, Epigenetics, and Programming Stem Cell Renewal and Differentiation: Implications for Stem Cell Therapy 35. Aging and Disease: The Epigenetic Bridge 36. Epigenetic Programming of Human Disease and Aging Section IX: Future Research 37. Epigenetic Prospects in Epidemiology and Public Health |
|
|
|
|
ÀÌ ÃâÆÇ»çÀÇ °ü·Ã»óÇ° |
|
|
Nuclear Power Reactor Designs | Leon, Sama Bilbao Y.,Talabi, Sola,Wang, Jun | Academic Press |
|
Physiology of Woody Plants | Academic Press |
|
Stem Cells | Mummery, Christine,Van de Stolpe, Anja,Roelen, Bernard | Academic Press |
|
Advances in Heterocyclic Chemistry | Ramsden, Christopher A.,Scriven, Eric | Academic Press |
|
Advances in Organometallic Chemistry | Perez, Pedro J. | Academic Press |
|
|
|
|
|
Ãâ°í¾È³» |
|
|
Ãâ°í¶õ ÀÎÅÍÆÄÅ© ¹°·ùâ°í¿¡¼ µµ¼°¡ Æ÷ÀåµÇ¾î ³ª°¡´Â ½ÃÁ¡À» ¸»Çϸç, ½ÇÁ¦ °í°´´Ô²²¼ ¼ö·ÉÇϽô ½Ã°£Àº »óÇ°Áغñ¿Ï·áÇØ Ãâ°íÇÑ ³¯Â¥ + Åùè»ç ¹è¼ÛÀÏÀÔ´Ï´Ù. |
|
ÀÎÅÍÆÄÅ© µµ¼´Â ¸ðµç »óÇ°ÀÇ Àç°í°¡ ÃæÁ·ÇÒ ½Ã¿¡ ÀÏ°ý Ãâ°í¸¦ ÇÕ´Ï´Ù. |
|
ÀϺΠÀç°í¿¡ ´ëÇÑ Ãâ°í°¡ ÇÊ¿äÇÒ ½Ã¿¡´Â ´ã´çÀÚ¿¡°Ô Á÷Á¢ ¿¬¶ôÇϽðųª, °í°´¼¾ÅÍ(°í°´¼¾ÅÍ(1577-2555)·Î ¿¬¶ôÁֽñ⠹ٶø´Ï´Ù. |
|
¹è¼Ûºñ ¾È³» |
|
|
ÀÎÅÍÆÄÅ© µµ¼ ´ë·®±¸¸Å´Â ¹è¼Û·á°¡ ¹«·áÀÔ´Ï´Ù. |
|
´Ü, 1°³ÀÇ »óÇ°À» ´Ù¼öÀÇ ¹è¼ÛÁö·Î ÀÏ°ý ¹ß¼Û½Ã¿¡´Â 1°³ÀÇ ¹è¼ÛÁö´ç 2,000¿øÀÇ ¹è¼Ûºñ°¡ ºÎ°úµË´Ï´Ù. |
¾Ë¾ÆµÎ¼¼¿ä! |
|
|
°í°´´Ô²²¼ ÁÖ¹®ÇϽŠµµ¼¶óµµ µµ¸Å»ó ¹× ÃâÆÇ»ç »çÁ¤¿¡ µû¶ó Ç°Àý/ÀýÆÇ µîÀÇ »çÀ¯·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù. |
|
Åùè»ç ¹è¼ÛÀÏÀÎ ¼¿ï ¹× ¼öµµ±ÇÀº 1~2ÀÏ, Áö¹æÀº 2~3ÀÏ, µµ¼, »ê°£, ±ººÎ´ë´Â 3ÀÏ ÀÌ»óÀÇ ½Ã°£ÀÌ ¼Ò¿äµË´Ï´Ù.
(´Ü, Åä/ÀÏ¿äÀÏ Á¦¿Ü) |
|
|
|
|
ÀÎÅÍÆÄÅ©µµ¼´Â °í°´´ÔÀÇ ´Ü¼ø º¯½É¿¡ ÀÇÇÑ ±³È¯°ú ¹ÝÇ°¿¡ µå´Â ºñ¿ëÀº °í°´´ÔÀÌ ÁöºÒÄÉ µË´Ï´Ù.
´Ü, »óÇ°À̳ª ¼ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯ ¹× ¹ÝÇ°Àº ¹«·á·Î ¹ÝÇ° µË´Ï´Ù.
±³È¯/¹ÝÇ°/º¸ÁõÁ¶°Ç ¹× Ç°Áúº¸Áõ ±âÁØÀº ¼ÒºñÀڱ⺻¹ý¿¡ µû¸¥ ¼ÒºñÀÚ ºÐÀï ÇØ°á ±âÁØ¿¡ µû¶ó ÇÇÇظ¦ º¸»ó ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.
Á¤È®ÇÑ È¯ºÒ ¹æ¹ý ¹× ȯºÒÀÌ Áö¿¬µÉ °æ¿ì 1:1¹®ÀÇ °Ô½ÃÆÇ ¶Ç´Â °í°´¼¾ÅÍ(1577-2555)·Î ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù.
¼ÒºñÀÚ ÇÇÇغ¸»óÀÇ ºÐÀïó¸® µî¿¡ °üÇÑ »çÇ×Àº ¼ÒºñÀÚºÐÀïÇØ°á±âÁØ(°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ µû¶ó ºñÇØ º¸»ó ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù.
|
±³È¯ ¹× ¹ÝÇ°ÀÌ °¡´ÉÇÑ °æ¿ì |
|
|
»óÇ°À» °ø±Þ ¹ÞÀ¸½Å ³¯·ÎºÎÅÍ 7ÀÏÀ̳» °¡´ÉÇÕ´Ï´Ù. |
|
°ø±Þ¹ÞÀ¸½Å »óÇ°ÀÇ ³»¿ëÀÌ Ç¥½Ã, ±¤°í ³»¿ë°ú ´Ù¸£°Å³ª ´Ù¸£°Ô ÀÌÇàµÈ °æ¿ì¿¡´Â °ø±Þ¹ÞÀº ³¯·ÎºÎÅÍ 3°³¿ùÀ̳», ±×»ç½ÇÀ» ¾Ë°Ô µÈ ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏÀ̳» °¡´ÉÇÕ´Ï´Ù. |
|
»óÇ°¿¡ ¾Æ¹«·± ÇÏÀÚ°¡ ¾ø´Â °æ¿ì ¼ÒºñÀÚÀÇ °í°´º¯½É¿¡ ÀÇÇÑ ±³È¯Àº »óÇ°ÀÇ Æ÷Àå»óÅ µîÀÌ ÀüÇô ¼Õ»óµÇÁö ¾ÊÀº °æ¿ì¿¡ ÇÑÇÏ¿© °¡´ÉÇÕ´Ï´Ù.
|
|
|
|
±³È¯ ¹× ¹ÝÇ°ÀÌ ºÒ°¡´ÉÇÑ °æ¿ì |
|
|
|
°í°´´ÔÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¸ê½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. (´Ü, »óÇ°ÀÇ ³»¿ëÀ» È®ÀÎÇϱâ À§ÇÏ¿© Æ÷Àå µîÀ» ÈѼÕÇÑ °æ¿ì´Â Á¦¿Ü) |
|
½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀçÆǸŰ¡ °ï¶õÇÒ Á¤µµ·Î ¹°Ç°ÀÇ °¡Ä¡°¡ ¶³¾îÁø °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. |
|
Æ÷Àå °³ºÀµÇ¾î »óÇ° °¡Ä¡°¡ ÈÑ¼ÕµÈ °æ¿ì´Â ºÒ°¡´ÉÇÕ´Ï´Ù. |
|
|
´Ù¹è¼ÛÁöÀÇ °æ¿ì ¹ÝÇ° ȯºÒ |
|
|
|
´Ù¹è¼ÛÁöÀÇ °æ¿ì ´Ù¸¥ Áö¿ªÀÇ ¹ÝÇ°À» µ¿½Ã¿¡ ÁøÇàÇÒ ¼ö ¾ø½À´Ï´Ù. |
|
1°³ Áö¿ªÀÇ ¹ÝÇ°ÀÌ ¿Ï·áµÈ ÈÄ ´Ù¸¥ Áö¿ª ¹ÝÇ°À» ÁøÇàÇÒ ¼ö ÀÖÀ¸¹Ç·Î, ÀÌÁ¡ ¾çÇØÇØ Áֽñ⠹ٶø´Ï´Ù. |
|
|
|
|
|
|